Dr. Mize has more than 15 years experience in Biotechnology with extensive experience in novel genomics and proteomics applications, innovative technology implementation, and expertise in Pharmacogenomics and Pharmacoproteomics. Her experience also includes drug and peptide modeling (QSAR for toxicity), microarray Genechip analysis, and Mass Spectroscopy. As a consultant, Dr. Mize has reviewed and appraised technologies for several startup Biotechnology companies, composed business plans and prepared slideware. As Director of Protein Bioinformatics at Hyseq Pharmaceuticals, a Genomics company, she created and supervised three groups: Computational Biology, Intellectual Property Informatics, and Data Integration. Previously, Dr. Mize was research scientist at Ciphergen Biosystems, a Proteomics company, and staff scientist at Alza Corp. She received her B.S. from the University of California, Berkeley, and her Ph.D. from the University of California, San Francisco. Subsequently, she completed postdoctoral studies in the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL, GenBank), Heidelberg, Germany, and at Genentech in the Department of Molecular Biology. In the course of her work at Ciphergen and Hyseq Pharmaceuticals, Dr. Mize holds more than 25 U.S. and European patent applications, with 4 issued patents to date. Dr. Mize works with DNA Bridges, Inc. www.dnabridges.com a firm known internationally for expert consulting and professional services in biotechnology, pharmaceutical and diagnostic industries, and she works with Pacific BioDevelopment www.pacbiodev.com performing PharmacoGenomics and PharmacoProteomics for clinical trials. In addition, she serves on the Strategic Planning Committee for the life sciences division of the Women's Technology Cluster www.wtc-sf.org an incubator for startup information technology and biotechnology businesses.